Patents Assigned to BIONOR PHARMA ASA
  • Patent number: 10143737
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods to select HIV infected patients with improved responses to HIV-specific vaccine peptides.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: December 4, 2018
    Assignee: BIONOR PHARMA ASA
    Inventors: Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold